Compugen Reports Second Quarter 2023 Results
Advancing enrollment in two proof-of-concept studies evaluating triple blockade of DNAM-1 axis in patients with microsatellite stable colorectal cancer and...
Source: prnewswire.com
Planned Milestones News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Planned Milestones. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Planned Milestones Today - Breaking & Trending Today
Curis Reports Second Quarter 2022 Financial Results and Business Update
/PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today...
Source: prnewswire.com
Curis Reports Second Quarter 2022 Financial Results and Business Update
/PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today...
Source: prnewswire.com
Curis Reports First Quarter 2022 Financial Results and Business Update
/PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today...
Source: prnewswire.com
Ortho Regenerative Technologies Well-positioned for Next Phase of Development
Ortho RTI" or the " Company"), a clinical stage orthobiologics company focused on the development of novel soft tissue repair regenerative technologies, today provided a review of 2020 calendar year activities and a look forward at planned future milestones as the Company transitions from preclinical to clinical stage. 2020 Achievements Completed four non-brokered private placements that raised an aggregate C$6.7 million. The company now has more than $2 million cash on hand to fund its regulatory and clinical stage projects through 2022. In March and July, Ortho RTI announced positive precl...
Source: prnewswire.com